Labomed Pharmaceutical competitive analysis

Explore patent oppositions filed by Labomed Pharmaceutical against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 6, 2026
Patent NumberTitleApplicantOpposition Date
Aqueous Pharmaceutical Formulation Of Tapentadol For Oral AdministrationGRNENTHALJan 22, 2021

Explore Labomed Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 6, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 1, 2025Container Comprising A Lisdexamfetamine Containing Oral Solution1
Jul 27, 2022Oral Solutions Comprising Lisdexamfetamine Salts1

Latest PTAB cases involving Labomed Pharmaceutical

Discover the latest PTAB cases involving Labomed Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Labomed Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 6, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LABOMED PHARMACEUTICAL COMPAMY1 - - -
GRNENTHAL - 231 -